Thursday, February 09, 2017 4:59:12 PM
Patience is required. It takes more than 9 months to design/validate new product, establish/launch a mfg base, identify/penetrate new markets and finally record sales and generate FCF. Moreover, doing this without significant funding and simultaneously challenging a Fortune 50 concern to stay afloat. Hopefully the principle based approach will win out.
The noise on this board should not deter the l-t approach. I have personally spoken to the CEO and I have skin in the gsme and will be patient to see it thru. It's an OTC stock with many risks. It's also a stock that generates polarized opinions. Time will tell which camp is right, the rest is just opinion and clutter.
FEATURED DaBaby and Stunna 4 Vegas's "NO DRIBBLE" Joins Music Licensing, Inc.'s Portfolio • Jun 7, 2024 10:15 AM
Mushrooms Inc. (OTC: MSRM) Announces Significant Share Buy Back by the Board Director and New Strategic Initiatives. • MSRM • Jun 5, 2024 1:32 PM
Hydromer Announces Launch of HydroThrombX Medical Device Coating Technology • HYDI • Jun 5, 2024 10:24 AM
Dr. Michael Dent Finances $1 Million to Drive HealthLynked's Healthcare Transformation • HLYK • Jun 5, 2024 8:00 AM
Avant Technologies Enters Binding LOI to Purchase Dozens of High-Performance, Immersible, AI-Powered Servers • AVAI • Jun 5, 2024 8:00 AM
IQST - iQSTEL Announces $290 Million 2024 Annual Revenue Forecast • IQST • Jun 4, 2024 1:43 PM